Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region

Most disease-modifying drugs (DMDs) are contraindicated in pregnancy. Management of MS is especially challenging for pregnant patients, as withdrawal of DMDs leave the patient at risk of increased disease activity. We, a group of experts in MS care from countries in the Arab Gulf, present our consen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurol Ther
Main Authors: Alroughani, Raed, Inshasi, Jihad, Al-Asmi, Abdullah, Alkhabouri, Jaber, Alsaadi, Taoufik, Alsalti, Abdullah, Boshra, Amir, Canibano, Beatriz, Ahmed, Samar Farouk, Shatila, Ahmed
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7606397/
https://ncbi.nlm.nih.gov/pubmed/32564333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-020-00201-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados